The GENESPRING brand, founded in 2000 (United States), from 274 sister brands and 2617 competing brands. GENESPRING is a brand of Agilent Technologies, Inc., listed on the stock exchange of New York. GENESPRING is part of the Medical Diagnostics & Research activity sector.
Investment simulator :
Portfolio valuation
Agilent Technologies, Inc.
(GENESPRING)
over 5 years*
USD 238.94